neuro42 appoints Krishna Bhupal to its BOD

neuro42, Inc. announced it has appointed its lead investor, Krishna Bhupal, to its Board of Directors. Bhupal is an accomplished entrepreneur and investor who has demonstrated a track record of delivering significant shareholder value. His current involvements are in the following key industries: energy, hospitality, retail and real estate. His current investments are focused on the Deep Tech space, including MedTech, and includes over 12 companies at various stages of maturity.

“We are excited to have Krishna Bhupal join the neuro42 team. His experience across many sectors will help us navigate the ever-changing global landscape and we look forward to his guidance as we drive awareness and market penetration of our differentiated technology,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42. “We are executing to plan and having a seasoned entrepreneur like Krishna on our board gives us the advantage of an advisor and investor who is supportive of our mission to advance MRI from screening to robotic intervention.”

Bhupal said, “I am delighted to continue to be a part of neuro42’s journey to develop and market pioneering MR technologies for neurosurgical intervention. I look forward to the Company’s next phase of growth and for it be a pioneer in the imaging and robotics space in America.”
MB Bureau